A Randomized, Double-Blind, Multicenter, Phase 3 Study o

  • Dunn, Ty B (PI)

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of 28 Weeks of Brincidofovir versus Valganciclovir for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
StatusFinished
Effective start/end date7/20/152/15/16

Funding

  • Chimerix, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.